Penn Medicine Creates New Role Overseeing Data and Technology Solutions

Penn Medicine in Philadelphia has created a new position of senior vice president of data and technology solutions that will oversee the offices of the chief information officer, chief medical information officer and chief analytics officer.

Mitchell Schnall, M.D., Ph.D., was appointed to the new position, following two terms as chair of Radiology at Penn’s Perelman School of Medicine. You will lead the health system’s efforts to understand new tools and approaches and determine how best to implement them across the health system to improve the provider experience, improve health outcomes for patients, and drive efficiencies across the system. of health. These include tools to automate patient access, tracking, and self-service transactions.

Penn Medicine is an $11.1 billion company with more than 49,000 faculty and staff.

“Penn Medicine is excited to take advantage of emerging opportunities to use technology in ways that will transform the healthcare industry,” Kevin Mahoney, CEO of the University of Pennsylvania Health System (UPHS), said in a statement. “Dr. Schnall is a talented and visionary leader who will help us leverage our institution’s longstanding culture of innovation and continuous learning in this new space, and provide a roadmap for health systems across the country.”

During his two terms as chair of radiology, Schnall doubled the size of the department and its research funding portfolio. Developed training programs and funding pathways for clinical scientists in Radiology, unified academic programs across UPHS hospitals in Philadelphia, and created a unique Penn Medicine Radiology residency that the health system says has been named the best radiology program from the country.

Penn Medicine also credits Schnall for developing a strong collaboration between the department’s community physicians and its academic programs. Additionally, he created a framework for “One Penn Medicine Radiology,” which he will continue to lead as he assumes his new role. He will continue to play a leadership role in the ECOG-ACRIN Cancer Research Group.

We will be happy to hear your thoughts

Leave a reply

Compare items
  • Total (0)